Inhibition of colony stimulating factor 1 receptor corrects maternal inflammation-induced microglial and synaptic

Seiko Ikezu1, Hana Yeh2,3, Jean-Christophe Delpech2

  • 1Departments of Pharmacology and Experimental Therapeutics, Boston University School of Medicine, Boston, MA, USA. sikezu@bu.edu.

Molecular Psychiatry
|February 20, 2020
PubMed

Insights

Maternal immune activation in mice alters brain immune cells (microglia) and causes behavioral issues. Targeting microglia with specific inhibitors corrected these neurodevelopmental and behavioral problems.

Area of Science:

  • Neuroscience
  • Immunology
  • Developmental Biology

Background:

  • Maternal immune activation (MIA) impacts fetal brain development.
  • The role of microglia in MIA's effects on neurodevelopment is not fully understood.

Purpose of the Study:

  • Investigate how MIA affects microglial gene expression and brain function.
  • Determine if targeting microglia can reverse MIA-induced neurobehavioral deficits.

Main Methods:

  • MIA model in mice.
  • Analysis of microglial gene expression.
  • Behavioral testing.
  • Synaptic function assessment.
  • Treatment with colony stimulating factor 1 receptor inhibitors.

Main Results:

  • MIA altered microglial pathways and caused synaptic dysfunction and behavioral deficits in offspring.
  • MIA increased dendritic spines and microglial interaction with neurons.
  • Microglia-targeted therapy corrected molecular, synaptic, and behavioral abnormalities.

Conclusions:

  • Maternal immune insults disrupt microglial function, impacting neuronal development and behavior long-term.
  • Colony stimulating factor 1 receptor inhibitors show therapeutic potential for MIA-associated neurodevelopmental disorders.